Concomitant targeting of tumor cells and induction of T cell response synergizes to effectively inhibit trastuzumab-resistant breast cancer.

被引：0
|
作者：
Wang, Qingfei [1 ]
Li, Shau-Hsuan [1 ]
Wang, Hai [1 ]
Xiao, Yi [1 ]
Sahin, Ozgur [1 ]
Brady, Samuel W. [1 ]
Li, Ping [1 ]
Jaffee, Elizabeth M. [2 ,3 ]
Hortobagyi, Gabriel N. [1 ]
Yu, Dihua [1 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
[2] Sidney Kimmel Canc Ctr Johns Hopkins, Baltimore, MD USA
[3] Viragh Pancreat Canc Ctr, Baltimore, MD USA
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-LB-215
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB215
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Concomitant Targeting of Tumor Cells and Induction of T-cell Response Synergizes to Effectively Inhibit Trastuzumab-Resistant Breast Cancer
    Wang, Qingfei
    Li, Shau-Hsuan
    Wang, Hai
    Xiao, Yi
    Sahin, Ozgur
    Brady, Samuel W.
    Li, Ping
    Ge, Hailiang
    Jaffee, Elizabeth M.
    Muller, William J.
    Hortobagyi, Gabriel N.
    Yu, Dihua
    CANCER RESEARCH, 2012, 72 (17) : 4417 - 4428
  • [2] Anthocyanins inhibit trastuzumab-resistant breast cancer in vitro and in vivo
    Li, Xin
    Xu, Jinmei
    Tang, Xi
    Liu, Yilun
    Yu, Xiaoping
    Wang, Zhi
    Liu, Weihua
    MOLECULAR MEDICINE REPORTS, 2016, 13 (05) : 4007 - 4013
  • [3] In vitro effects of trastuzumab and vinorelbine in trastuzumab-resistant breast cancer cells
    Nahta, R
    Esteva, FJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2004, 53 (02) : 186 - 190
  • [4] In vitro effects of trastuzumab and vinorelbine in trastuzumab-resistant breast cancer cells
    Rita Nahta
    Francisco J. Esteva
    Cancer Chemotherapy and Pharmacology, 2004, 53 : 186 - 190
  • [5] Targeting trastuzumab-resistant HER2+breast cancer with a HER3-targeting nanoparticle
    Sims, Jessica
    Taguaim, Michael
    Hanson, Chris
    Cui, Xiaojiang
    Medina-Kauwe, Lali K.
    CANCER RESEARCH, 2014, 74 (19)
  • [6] Targeting trastuzumab-resistant breast cancer cells with a lentivirus engineered to bind antibodies that recognize HER-2
    Kai-xin Zhang
    Connie Kim
    Elaine Chow
    Irvin S. Y. Chen
    William Jia
    Paul S. Rennie
    Breast Cancer Research and Treatment, 2011, 125 : 89 - 97
  • [7] Targeting trastuzumab-resistant breast cancer cells with a lentivirus engineered to bind antibodies that recognize HER-2
    Zhang, Kai-xin
    Kim, Connie
    Chow, Elaine
    Chen, Irvin S. Y.
    Jia, William
    Rennie, Paul S.
    BREAST CANCER RESEARCH AND TREATMENT, 2011, 125 (01) : 89 - 97
  • [8] Genomic and gene expression characterization of a novel trastuzumab-resistant breast cancer cell line
    Balazs, M.
    Barok, M.
    Lazar, V.
    Rakosy, Z.
    Toth, E.
    Park, J.
    Szollosi, J.
    EJC SUPPLEMENTS, 2008, 6 (09): : 119 - 119
  • [9] A pathway-based approach for identifying biomarkers of tumor progression to trastuzumab-resistant breast cancer
    Nam, Seungyoon
    Chang, Hae Ryung
    Jung, Hae Rim
    Gim, Youme
    Kim, Nam Youl
    Grailhe, Regis
    Seo, Haeng Ran
    Park, Hee Seo
    Balch, Curt
    Lee, Jinhyuk
    Park, Inhae
    Jung, So Youn
    Jeong, Kyung-Chae
    Powis, Garth
    Liang, Han
    Lee, Eun Sook
    Ro, Jungsil
    Kim, Yon Hui
    CANCER LETTERS, 2015, 356 (02) : 880 - 890
  • [10] MGB1 regulates aggressiveness of Trastuzumab-resistant breast cancer cells.
    Kusumastuti, Ratih
    Kumagai, Yuji
    Ishihara, Seiichiro
    Haga, Hisashi
    CANCER SCIENCE, 2021, 112 : 341 - 341
12345